Non-pharmacological therapy options for chemotherapy-related cognitive impairment
نویسندگان
چکیده
AMA Piechowicz P, Dunaj Janota A, Kołodziejczyk K, Dzierżanowski T. Non-pharmacological therapy options for chemotherapy-related cognitive impairment. Medycyna Paliatywna/Palliative Medicine. 2022;14(4):173-182. doi:10.5114/pm.2022.127038. APA Piechowicz, P., Dunaj, Janota, A., Kołodziejczyk, K., & Dzierżanowski, (2022). Medicine, 14(4), 173-182. https://doi.org/10.5114/pm.2022.127038 Chicago Paulina, Piotr Aleksandra Katarzyna and Tomasz Dzierżanowski. 2022. "Non-pharmacological impairment". Medicine 14 (4): Harvard pp.173-182. MLA Paulina et al. impairment." vol. 14, no. 4, 2022, pp. Vancouver
منابع مشابه
Chemotherapy and cognitive impairment: treatment options.
Chemotherapy has improved survival rates in patients with many of the common cancers. However, there is reliable evidence that, as a result of treatment, a subset of cancer survivors experience cognitive problems that can last for many years after the completion of chemotherapy. The etiology of this phenomenon is largely unknown, and currently there are no proven treatments. This article explor...
متن کاملNon-pharmacological options for fibromyalgia fatigue management
It has been evaluated that the fibromyalgia (FM) is prevalent in 1–3% of the population in the western world, but higher cases are reported in women. Widespread pain, tenderness and fatigue are some of the common characteristics of FM with symptoms of psychological distress and cognitive difficulties. In a present study, 82% of nearly 3000 patients with FM delineated severe fatigue, which was t...
متن کاملImprovement of Cognitive Impairment and Hallucination by Pharmacological and Non-pharmacological Therapies for a Parkinsonism’s Disease with Dementia
We reported a case of 80-years-old man with Parkinsonism Disease Dementia (PDD) who experienced an improvement of hallucination with decreasing dose of madopar and non-pharmacological therapies. The patient was initially diagnosed as Parkinson’s disease (PD) 15 years ago, and was medicated with madopar (dose of 250mg per day). The dose of madopar was gradually increased to 375mg per day during ...
متن کاملCognitive impairment after chemotherapy related to atypical network architecture for executive control.
OBJECTIVES A common complaint of cancer patients is the experience of cognitive difficulty during and after chemotherapy. We hypothesized that cognitive impairment may result from dysfunction in large-scale brain networks, particularly those involved in attentional control. METHODS Using a case-control design, this study includes women with a history of invasive ductal or lobular triple-negat...
متن کاملCombination drugs therapy delays diabetic induced cognitive impairment
p.p1 {margin: 0.0px 0.0px 10.0px 0.0px; font: 10.0px 'Times New Roman'; color: #000000; -webkit-text-stroke: #000000} span.s1 {font-kerning: none} Presently drugs that are available to treat the diabetic induced cognitive impairment presents adverse effect on long term used. This study offers evidence that old drugs can be combined and used. Existing and affordable drugs can be repurposed a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medycyna Paliatywna
سال: 2022
ISSN: ['2081-0016', '2081-2833']
DOI: https://doi.org/10.5114/pm.2022.127038